Back
Plus Therapeutics Stock Price Chart

Economic Policy Shifts = Huge Market Opportunity
See which of your stocks make the grade - analyze 3 stocks FREE.
Sell
10
PSTV
Plus Therapeutics
Last Price:
$0.32
Seasonality Move:
-17.42%
7 Day Trial
ALL ACCESS PASS
$
7

The EXACT DAY Certain Stocks Soar - Year After Year
Find out now - completely free of charge.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PSTV is experiencing slight buying pressure.
Plus Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.32 | Buy |
20-day SMA: | 0.4 | Sell |
50-day SMA: | 0.63 | Sell |
200-day SMA: | 1.1 | Sell |
8-day EMA: | 0.34 | Sell |
20-day EMA: | 0.4 | Sell |
50-day EMA: | 0.59 | Sell |
200-day EMA: | 1.08 | Sell |
Plus Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 38.76 | Sell |
Chaikin Money Flow: | 22231 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.3 - 0.58) | Sell |
Bollinger Bands (100): | (0.51 - 1.23) | Sell |
Plus Therapeutics Technical Analysis
May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Plus Therapeutics Stock
Is Plus Therapeutics Stock a Buy?
-
Plus Therapeutics share price is 0.33 while PSTV 8-day simple moving average is 0.32, which is a Buy signal.
-
The stock price of PSTV is 0.33 while Plus Therapeutics 20-day SMA is 0.40, which makes it a Sell.
-
Plus Therapeutics 50-day simple moving average is 0.63 while PSTV share price is 0.33, making it a Sell technically.
-
PSTV stock price is 0.33 and Plus Therapeutics 200-day simple moving average is 1.10, creating a Sell signal.
PSTV Technical Analysis vs Fundamental Analysis
Sell
10
Plus Therapeutics (PSTV)
is a Sell
Is Plus Therapeutics a Buy or a Sell?
-
Plus Therapeutics stock is rated a SellThe current Plus Therapeutics [PSTV] share price is $0.33. The Score for PSTV is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
Plus Therapeutics Stock Info
Market Cap:
10.6M
Price in USD:
0.33
Share Volume:
2.8M
Plus Therapeutics 52-Week Range
52-Week High:
2.55
52-Week Low:
0.24
Sell
10
Plus Therapeutics (PSTV)
is a Sell
Plus Therapeutics Share Price Forecast
-
What is the Plus Therapeutics stock price today?The Plus Therapeutics stock price is 0.33 USD today.
-
Will PSTV stock go up or go down?Plus Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Plus Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Plus Therapeutics is overvalued.
Is Plus Therapeutics Stock a Buy?
-
Plus Therapeutics share price is 0.33 while PSTV 8-day exponential moving average is 0.34, which is a Sell signal.
-
The stock price of PSTV is 0.33 while Plus Therapeutics 20-day EMA is 0.40, which makes it a Sell.
-
Plus Therapeutics 50-day exponential moving average is 0.59 while PSTV share price is 0.33, making it a Sell technically.
-
PSTV stock price is 0.33 and Plus Therapeutics 200-day simple moving average is 1.08, creating a Sell signal.
Fundamental Analysis of Plus Therapeutics
Is Plus Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.33 per share, an increase next quarter of $0.08 per share, an increase this year of $1.24 per share, and an increase next year of $0.07 per share.
Technical Analysis of Plus Therapeutics
Should I short Plus Therapeutics stock?
-
PSTV Moving Average Covergence Divergence (MACD) indicator is -0.09, suggesting Plus Therapeutics is a Sell
-
Plus Therapeutics Relative Strength Index (RSI) is 38.76, which suggest Plus Therapeutics is oversold
-
The Bollinger Bands (25) for Plus Therapeutics is (0.3 - 0.58), which suggest Plus Therapeutics is a Sell
-
The Bollinger Bands (100) for Plus Therapeutics is (0.51 - 1.23), which suggest Plus Therapeutics is a Sell
* Plus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.